Page last updated: 2024-10-20

pyrogallol and Acute Lymphoid Leukemia

pyrogallol has been researched along with Acute Lymphoid Leukemia in 1 studies

benzenetriol : A triol in which three hydroxy groups are substituted onto a benzene ring.

Research Excerpts

ExcerptRelevanceReference
"The IGF1R/IRS1 signaling is activated in acute lymphoblastic leukemia (ALL) and can be targeted by the pharmacological inhibitors NT157 (IGF1R-IRS1/2 inhibitor) and OSI-906 (IGF1R/IR inhibitor)."1.51IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells. ( Coelho-Silva, JL; Fenerich, BA; Fernandes, JC; Machado-Neto, JA; Rego, EM; Ridley, AJ; Rodrigues Alves, APN; Scheucher, PS; Simões, BP; Traina, F, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodrigues Alves, APN1
Fernandes, JC1
Fenerich, BA1
Coelho-Silva, JL1
Scheucher, PS1
Simões, BP1
Rego, EM1
Ridley, AJ1
Machado-Neto, JA1
Traina, F1

Other Studies

1 other study available for pyrogallol and Acute Lymphoid Leukemia

ArticleYear
IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells.
    Cancer letters, 2019, 08-01, Volume: 456

    Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Humans; Imidazoles; I

2019